{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T02:32:41Z","timestamp":1780972361668,"version":"3.54.1"},"reference-count":88,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Background\/objectives: Psoriasis is a chronic inflammatory autoimmune disease with important systemic and psychosocial impacts. The association with metabolic syndrome (MS) impairs disease severity and negatively influences patient-reported outcomes, particularly their quality of life as measured by the Dermatology Life Quality Index (DLQI). This study aims to investigate the relationship between systemic inflammation, DLQI scores and disease severity, focusing on the persistent impact of MS on patient outcomes after one year of treatment. Methods: This retrospective cross-sectional study included 150 psoriasis patients, with 74 also meeting the diagnostic criteria for MS. Clinical and inflammatory markers such as systemic immune\u2013inflammatory index (SII), cytokines (IL-17A, IL-23), leptin, BMI and triglycerides were analyzed alongside PASI and DLQI scores. Results: Patients with MS had significantly higher PASI and DLQI scores compared to those without MS, reflecting worse disease severity and quality of life (p &lt; 0.01). Elevated SII levels were strongly associated with higher DLQI scores (p &lt; 0.01). Despite considerable reductions in PASI scores over one year of treatment, DLQI scores indicated a persistent negative impact of MS on quality of life. Notably, markers of systemic inflammation, such as SII, leptin and cytokines, correlated positively with both PASI and DLQI scores, highlighting the role of systemic inflammation in disease burden. Conclusions: This study underlines the significant role of systemic inflammation and metabolic comorbidities in amplifying the burden of psoriasis. The persistent impact of MS on quality of life despite clinical improvement underscores the need for comprehensive treatment approaches targeting systemic inflammation, metabolic health and psychosocial factors to improve long-term outcomes.<\/jats:p>","DOI":"10.3390\/life15020212","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T04:05:47Z","timestamp":1738296347000},"page":"212","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association Between Systemic Inflammation, Metabolic Syndrome and Quality of Life in Psoriasis Patients"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6701-0760","authenticated-orcid":false,"given":"Maria-Lorena","family":"Musta\u021b\u0103","sequence":"first","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7150-5987","authenticated-orcid":false,"given":"Carmen-Daniela","family":"Neagoe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9028-7583","authenticated-orcid":false,"given":"Virginia-Maria","family":"R\u0103dulescu","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Biostatistics, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana-Gabriela","family":"Dragne","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu-Cristian","family":"C\u00eempeanu","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucre\u021biu","family":"Radu","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana-Viorela","family":"Ahri\u021bculesei","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drago\u0219","family":"For\u021bofoiu","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Cristina","family":"Predoi","sequence":"additional","affiliation":[{"name":"Department of Morphology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona-Laura","family":"Iano\u0219i","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jaad.2007.07.023","article-title":"Association of Patient-Reported Psoriasis Severity with Income and Employment","volume":"57","author":"Horn","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The Concept of Psoriasis as a Systemic Inflammation: Implications for Disease Management","volume":"26","author":"Reich","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/jdv.15450","article-title":"Itch: An Under-Recognized Problem in Psoriasis","volume":"33","author":"Elewski","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/09546634.2019.1572865","article-title":"Psoriasis-Associated Itch: Etiology, Assessment, Impact, and Management","volume":"31","author":"Pithadia","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e3263","DOI":"10.1002\/smi.3263","article-title":"Psychosocial Stress Affects the Change of Mental Distress under Dermatological Treatment\u2014A Prospective Cohort Study in Patients with Psoriasis","volume":"40","author":"Wintermann","year":"2024","journal-title":"Stress Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40257-015-0169-x","article-title":"US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey","volume":"17","author":"Lebwohl","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and Comorbid Diseases","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bu, J., Ding, R., Zhou, L., Chen, X., and Shen, E. (2022). Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.880201"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1346-8138.2009.00777.x","article-title":"Comorbidities Associated with Psoriasis: An Experience from the Middle East","volume":"37","year":"2010","journal-title":"J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study","volume":"157","author":"Gisondi","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archderm.144.12.1571","article-title":"Psoriasis Independently Associated With Hyperleptinemia Contributing to Metabolic Syndrome","volume":"144","author":"Chen","year":"2008","journal-title":"Arch. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-0770","article-title":"Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany","volume":"90","author":"Augustin","year":"2010","journal-title":"Acta Derm.-Venereol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.14706","article-title":"Metabolic Syndrome and Psoriatic Arthritis among Patients with Psoriasis Vulgaris: Quality of Life and Prevalence","volume":"46","author":"Souza","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the Metabolic Syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A Comprehensive Definition for Metabolic Syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.32415\/jscientia_2021_7_6_6-16","article-title":"BIOCHEMICAL PATHWAYS of METABOLIC DISORDERS in PSORIASIS","volume":"7","author":"Samburskaya","year":"2021","journal-title":"Juvenis Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.11622\/smedj.2019152","article-title":"Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Cross-Sectional Study in Singapore","volume":"61","author":"Chan","year":"2020","journal-title":"Singap. Med. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of Psoriasis as a Systemic Disease: What Is the Evidence?","volume":"182","author":"Korman","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jid.2020.11.025","article-title":"Causal Relationship and Shared Genetic Loci between Psoriasis and Type 2 Diabetes through Trans-Disease Meta-Analysis","volume":"141","author":"Patrick","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Gisondi, P., Bellinato, F., Girolomoni, G., and Albanesi, C. (2020). Pathogenesis of Chronic Plaque Psoriasis and Its Intersection with Cardio-Metabolic Comorbidities. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00117"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-14365-1","article-title":"IFN-\u03b3 and TNF-\u03b1 Synergism May Provide a Link between Psoriasis and Inflammatory Atherogenesis","volume":"7","author":"Mehta","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12967-014-0258-2","article-title":"Characterization of Immune Cells in Psoriatic Adipose Tissue","volume":"12","author":"Rose","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/bjd.12118","article-title":"Serum Chemerin Is Increased in Patients with Chronic Plaque Psoriasis and Normalizes Following Treatment with Infliximab","volume":"168","author":"Gisondi","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/PTT.S328447","article-title":"Assessing and Improving Psychological Well-Being in Psoriasis: Considerations for the Clinician","volume":"12","author":"Blackstone","year":"2022","journal-title":"Psoriasis Targets Ther."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Huang, T.-H., Lin, C.-F., Alalaiwe, A., Yang, S.-C., and Fang, J.-Y. (2019). Apoptotic or Antiproliferative Activity of Natural Products against Keratinocytes for the Treatment of Psoriasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102558"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Scuderi, S.A., Cucinotta, L., Filippone, A., Lanza, M., Campolo, M., Paterniti, I., and Esposito, E. (2022). Effect of Melatonin on Psoriatic Phenotype in Human Reconstructed Skin Model. Biomedicines, 10.","DOI":"10.3390\/biomedicines10040752"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40257-017-0279-8","article-title":"Psoriasis, Depression, and Inflammatory Overlap: A Review","volume":"18","author":"Patel","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Pistorio, M.L., Moretta, T., Musumeci, M.L., Russo, C., Lacarrubba, F., Petralia, A., Micali, G., and Pasquale, C.D. (2024). Impact of Attachment Style and Temperament Traits on the Quality of Life of Patients with Psoriasis. Behav. Sci., 14.","DOI":"10.3390\/bs14060434"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/jid.2013.508","article-title":"The Prevalence and Odds of Depressive Symptoms and Clinical Depression in Psoriasis Patients: A Systematic Review and Meta-Analysis","volume":"134","author":"Dowlatshahi","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/bjd\/ljac132","article-title":"Factors Associated with Depression, Anxiety and Severe Mental Illness among Adults with Atopic Eczema or Psoriasis: A Systematic Review and Meta-Analysis","volume":"188","author":"Adesanya","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/00015550510032832","article-title":"Psychometric Properties of the Dermatology Life Quality Index (DLQI) in 900 Italian Patients with Psoriasis","volume":"85","author":"Mazzotti","year":"2005","journal-title":"Acta Derm.-Venereol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)-a Simple Practical Measure for Routine Clinical Use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","article-title":"10 Years Experience of the Dermatology Life Quality Index (DLQI)","volume":"9","author":"Lewis","year":"2004","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_36","first-page":"553","article-title":"Study on the Impact of Psoriasis on Quality of Life: Psychological, Social and Financial Implications","volume":"32","author":"Bulat","year":"2020","journal-title":"Psychiatr. Danub."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00128071-200506060-00005","article-title":"The Psychosocial Burden of Psoriasis","volume":"6","author":"Kimball","year":"2005","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1515\/sjpain-2019-0158","article-title":"The Complex Experience of Psoriasis Related Skin Pain: A Qualitative Study","volume":"20","author":"Ljosaa","year":"2020","journal-title":"Scand. J. Pain"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jdv.12106","article-title":"Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation between Disease Severity and Psychological Burden in Patients Treated with Biological Therapies","volume":"28","author":"Mattei","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s13555-021-00564-2","article-title":"Correlation between Change in Psoriasis Area and Severity Index and Dermatology Life Quality Index in Patients with Psoriasis: Pooled Analysis from Four Phase 3 Clinical Trials of Secukinumab","volume":"11","author":"Houghton","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e13276","DOI":"10.1111\/dth.13276","article-title":"The Relationship between PASI and DLQI with Itch, Stress, and Depression: Do We Need Additional Decision-Making Tools in Psoriasis?","volume":"33","author":"Mueller","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"109780","DOI":"10.1016\/j.jpsychores.2019.109780","article-title":"Quality of Life, Anxiety and Depressive Symptoms in Patients with Psoriasis: A Case-Control Study","volume":"124","author":"Nogueras","year":"2019","journal-title":"J. Psychosom. Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Fuat, M.S.A., Yudin, Z.M., Muhammad, J., and Zin, F.M. (2022). Quality of Life and Its Associated Factors among Patients with Psoriasis in a Semi-Urban Northeast Malaysia. IJERPH, 19.","DOI":"10.3390\/ijerph191811578"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1468-3083.2000.00085.x","article-title":"The Depression, Anxiety, Life Satisfaction and Affective Expression Levels in Psoriasis Patients","volume":"14","author":"Kundakci","year":"2000","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_46","first-page":"185","article-title":"Quality of life in patients with psoriasis","volume":"153","year":"2017","journal-title":"Gac. Medica Mex."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-017-0721-x","article-title":"How is Disease Severity Associated with Quality of Life in Psoriasis Patients? Evidence from a Longitudinal Population-Based Study in Sweden","volume":"15","author":"Geale","year":"2017","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"562","DOI":"10.52403\/ijshr.20230276","article-title":"Emotional Turbulence Perceived by Psoriasis Patients","volume":"8","author":"Malsawmtluangi","year":"2023","journal-title":"Int. J. Sci. Healthc. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/381905","article-title":"Depression and Anxiety Disorders among Patients with Psoriasis: A Hospital-Based Case-Control Study","volume":"2012","author":"Golpour","year":"2012","journal-title":"Dermatol. Res. Pr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1365-2133.2002.04742.x","article-title":"Quality of Life in 6497 Nordic Patients with Psoriasis","volume":"146","author":"Zachariae","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0190-9622(98)70074-X","article-title":"What Patients with Psoriasis Believe about Their Condition","volume":"39","author":"Fortune","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e15104","DOI":"10.1111\/exd.15104","article-title":"Effects on Peripheral and Central Nervous System of Key Inflammatory Intercellular Signalling Peptides and Proteins in Psoriasis","volume":"33","author":"Tang","year":"2024","journal-title":"Exp. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature13199","article-title":"Nociceptive Sensory Neurons Drive Interleukin-23-Mediated Psoriasiform Skin Inflammation","volume":"510","author":"Perro","year":"2014","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Marek-Jozefowicz, L., Czajkowski, R., Borkowska, A., Nedoszytko, B., \u017bmijewski, M.A., Cuba\u0142a, W.J., and Slominski, A.T. (2022). The Brain\u2013Skin Axis in Psoriasis\u2014Psychological, Psychiatric, Hormonal, and Dermatological Aspects. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020669"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/bjd.12478","article-title":"Does Psychosocial Stress Play a Role in the Exacerbation of Psoriasis?","volume":"169","author":"Hunter","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/403908","article-title":"Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis","volume":"2012","author":"Hall","year":"2012","journal-title":"Dermatol. Res. Pract."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1586\/eci.12.1","article-title":"Stress, the Neuroendocrine System and Mast Cells: Current Understanding of Their Role in Psoriasis","volume":"8","author":"Harvima","year":"2012","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/409637","article-title":"Exploring the Physiological Link between Psoriasis and Mood Disorders","volume":"2015","author":"Connor","year":"2015","journal-title":"Dermatol. Res. Pr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cca.2019.06.019","article-title":"Metabolic Syndrome Is an Inflammatory Disorder: A Conspiracy between Adipose Tissue and Phagocytes","volume":"496","author":"Reddy","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11906-010-0096-4","article-title":"Central Adiposity, Systemic Inflammation, and the Metabolic Syndrome","volume":"12","author":"Elks","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/bjd.12002","article-title":"Association of Psoriasis with Stroke and Myocardial Infarction: Meta-Analysis of Cohort Studies","volume":"167","author":"Xu","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s12325-020-01346-6","article-title":"Psoriasis and Cardiovascular Risk: A Comprehensive Review","volume":"37","author":"Masson","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s13555-021-00590-0","article-title":"Psoriasis and Cardiometabolic Comorbidities: An Evaluation of the Impact of Systemic Treatments in Randomized Clinical Trials","volume":"11","author":"Mosca","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.det.2014.09.004","article-title":"Psoriasis is a Systemic Disease with Multiple Cardiovascular and Metabolic Comorbidities","volume":"33","author":"Ryan","year":"2015","journal-title":"Dermatol. Clin."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.18044","article-title":"Psoriasis and Metabolic Syndrome: Implications for the Management and Treatment of Psoriasis","volume":"36","author":"Wu","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Hu, S., and Lan, C.-C.E. (2017). Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102211"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Hao, Y., Zhu, Y., Zou, S., Zhou, P., Hu, Y., Zhao, Q., Gu, L., Zhang, H., Wang, Z., and Li, J. (2021). Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.711060"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Anyfanti, P., Margouta, A., Goulas, K., Gavriilaki, M., Lazaridou, E., Patsatsi, A., and Gkaliagkousi, E. (2022). Endothelial Dysfunction in Psoriasis: An Updated Review. Front. Med., 9.","DOI":"10.3389\/fmed.2022.864185"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ito, F., Sono, Y., and Ito, T. (2019). Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation. Antioxidants, 8.","DOI":"10.3390\/antiox8030072"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6642927","article-title":"The Entry and Egress of Monocytes in Atherosclerosis: A Biochemical and Biomechanical Driven Process","volume":"2021","author":"Kang","year":"2021","journal-title":"Cardiovasc. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/PTT.S54089","article-title":"Links and Risks Associated with Psoriasis and Metabolic Syndrome","volume":"5","author":"Liakou","year":"2015","journal-title":"Psoriasis Targets Ther."},{"key":"ref_73","first-page":"6","article-title":"Psoriasis and Obesity: A Review of the Current Literature","volume":"2","author":"Orloff","year":"2018","journal-title":"Ski. J. Cutan. Med."},{"key":"ref_74","first-page":"1","article-title":"Dyslipidemia in Psoriasis: A Case Controlled Study","volume":"2014","author":"Nakhwa","year":"2014","journal-title":"Int. Sch. Res. Not."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40257-016-0211-7","article-title":"Considerations for Systemic Treatment of Psoriasis in Obese Patients","volume":"17","author":"Gisondi","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s13555-022-00790-2","article-title":"Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review","volume":"12","author":"Merola","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Gargiulo, L., Ibba, L., Malagoli, P., Amoruso, F., Argenziano, G., Balato, A., Bardazzi, F., Burlando, M., Carrera, C.G., and Damiani, G. (2023). Brodalumab for the Treatment of Plaque Psoriasis in a Real-Life Setting: A 3 Years Multicenter Retrospective Study\u2014IL PSO (Italian Landscape Psoriasis). Front. Med., 10.","DOI":"10.3389\/fmed.2023.1196966"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2425029","DOI":"10.1080\/09546634.2024.2425029","article-title":"Long-Term Effectiveness and Safety of Risankizumab in Patients with Moderate-To-Severe Psoriasis with and without Cardiometabolic Comorbidities: A Single-Center Retrospective Study","volume":"35","author":"Ibba","year":"2024","journal-title":"J. Dermatol. Treat."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/CCID.S396997","article-title":"Psoriatic Foot Involvement Is the Most Significant Contributor to the Inconsistency Between PASI and DLQI: A Retrospective Study from China","volume":"16","author":"Yang","year":"2023","journal-title":"CCID"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2337\/dc06-1857","article-title":"Depressive Symptoms and Stressful Life Events Predict Metabolic Syndrome Among Middle-Aged Women","volume":"30","author":"Matthews","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s11136-011-0029-y","article-title":"Relationship between Health-Related Quality of Life and Clustering of Metabolic Syndrome Diagnostic Components","volume":"21","author":"Katano","year":"2012","journal-title":"Qual. Life Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.annepidem.2007.10.009","article-title":"Metabolic Syndrome and Health-Related Quality of Life among U.S. Adults","volume":"18","author":"Ford","year":"2008","journal-title":"Ann. Epidemiol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Lin, Y.-H., Chang, H.-T., Tseng, Y.-H., Chen, H.-S., Chiang, S.-C., Chen, T.-J., and Hwang, S.-J. (2021). Changes in Metabolic Syndrome Affect the Health-Related Quality of Life of Community-Dwelling Adults. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-99767-y"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/oby.21716","article-title":"Association between Weight Bias Internalization and Metabolic Syndrome among Treatment-Seeking Individuals with Obesity","volume":"25","author":"Pearl","year":"2017","journal-title":"Obesity"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Czarnecka, A., Zab\u0142otna, M., Purzycka-Bohdan, D., Nowicki, R.J., and Szczerkowska-Dobosz, A. (2023). An Observational Study of 147 Psoriasis Patients: Overweightness and Obesity as a Significant Clinical Factors Correlated with Psoriasis. Medicina, 59.","DOI":"10.3390\/medicina59112006"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"E837","DOI":"10.1111\/jdv.18895","article-title":"Systemic Immune-inflammation Biomarkers in Psoriasis Patients under Interleukin 17A -inhibitor Treatment","volume":"37","author":"Gambichler","year":"2023","journal-title":"Acad. Dermatol. Venereol."},{"key":"ref_87","first-page":"e48177","article-title":"Oxidative Stress and Inflammation Levels in a Population of Eastern European Na\u00efve Versus Treated Psoriasis Patients","volume":"15","author":"Cozma","year":"2023","journal-title":"Cureus"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Hagino, T., Saeki, H., Fujimoto, E., and Kanda, N. (2024). Long-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A 52-Week Real-World Study of Genital, Scalp, and Nail Lesions. Clin. Exp. Dermatol., llae530.","DOI":"10.1093\/ced\/llae530"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/2\/212\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:24:42Z","timestamp":1760027082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/2\/212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["life15020212"],"URL":"https:\/\/doi.org\/10.3390\/life15020212","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]}}}